Posted On: 03/13/2014 2:03:04 PM
Post# of 14
Latest Restorgenex Corporation (SMDID) Headlines
RestorGenex Names Stephen M. Simes as Chief Executive Officer
GlobeNewswire - Mon Mar 10, 6:13AM CDT
RestorGenex (OTCBB:SMDID) announced today that it has named Stephen M. Simes as its Chief Executive Officer, to lead the company. Mr. Simes formerly served as vice chairman, president, and CEO at BioSante Pharmaceuticals, Inc., a publicly held pharmaceutical company focused on developing products for women's and men's health and oncology that merged with ANI Pharmaceuticals, Inc. in 2013.
RestorGenex Names Stephen M. Simes as Chief Executive Officer
GlobeNewswire - Mon Mar 10, 6:13AM CDT
RestorGenex (OTCBB:SMDID) announced today that it has named Stephen M. Simes as its Chief Executive Officer, to lead the company. Mr. Simes formerly served as vice chairman, president, and CEO at BioSante Pharmaceuticals, Inc., a publicly held pharmaceutical company focused on developing products for women's and men's health and oncology that merged with ANI Pharmaceuticals, Inc. in 2013.
(0)
(0)
